The DOI matches its Crossref record; 86 of the 93 references it cites were found in a registry or an index.
Proautophagic Drugs: A Novel Means to Combat Apoptosis-Resistant Cancers, with a Special Emphasis on Glioblastomas
Abstract
Learning Objectives: After completing this course, the reader will be able to: Describe the pathways involved in the natural resistance of cancer cells to cytotoxic insults including radio-/chemotherapy.Explain autophagic cell death as a potent alternative tumor-suppressing mechanism.Identify the common targets in apoptosis and autophagy resistance pathways and the surrogate markers that could be used in clinical practice for proautophagic therapy.Discuss the rationale for incorporating endoplasmic reticulum stress inhibitors as adjuvant chemotherapies against apoptosis-resistant cancers. Access and take the CME test online and receive 1 AMA PRA Category 1 Credit™ at CME.TheOncologist.com
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As the suppression of autophagy to sustain the cytotoxicity of chemotherapeutic drugs is a novel strategy for cancer chemotherapy3435, HDAC10 is an emerging target for the treatment of advanced-stage neuroblastoma32.”
From Histone deacetylase 10 structure and molecular function as a polyamine deacetylase (2017) · cites this paper as [35]
Citations
Cites
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
Hegi, M. E., Diserens, A.-C., Gorlia, T., Hamou, M.-F., de Tribolet, N., Weller, M., Kros, J. M., Hainfellner, J. A., Mason, W., Mariani, L., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043331 · Cited by 7,405
Self-eating and self-killing: crosstalk between autophagy and apoptosis
Maiuri, M. C., Zalckvar, E., Kimchi, A., & Kroemer, G. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2239 · Cited by 3,638
Induction of autophagy and inhibition of tumorigenesis by beclin 1
Liang, X. H., Jackson, S., Seaman, M., Brown, K., Kempkes, B., Hibshoosh, H., & Levine, B. (1999) · Nature · doi:10.1038/45257 · Cited by 3,347
de Duve, C., & Wattiaux, R. (1966) · Annual Review of Physiology · doi:10.1146/annurev.ph.28.030166.002251 · Cited by 3,033 · cited 1×
“The autophagy story began in 1966 when De Duve and Wattiaux [ 28 ] discovered lysosomes, with the significance that autophagy is a lysosome-mediated degradation of proteins and cellular organelles [27].”
BackgroundAutophagy in Health and Disease: A Double-Edged Sword
Shintani, T., & Klionsky, D. J. (2004) · Science · doi:10.1126/science.1099993 · Cited by 2,559
The role of autophagy in cancer development and response to therapy
Kondo, Y., Kanzawa, T., Sawaya, R. A., & Kondo, S. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1692 · Cited by 1,673
Aggarwal, B. B. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.003 · Cited by 1,586
Growth factor regulation of autophagy and cell survival in the absence of apoptosis
Lum, J. J., Bauer, D. E., Kong, M., Harris, M. H., Li, C., Lindsten, T., & Thompson, C. B. (2005) · Cell · doi:10.1016/j.cell.2004.11.046 · Cited by 1,487
Autophagy as a cell death and tumor suppressor mechanism
Gözüaçık, D., & Kimchi, A. (2004) · Oncogene · doi:10.1038/sj.onc.1207521 · Cited by 1,396
Cited by
Sorted by citations
Induction of autophagy by spermidine promotes longevity
Eisenberg, T., Knauer, H., Schauer, A., Büttner, S., Ruckenstuhl, C., Carmona-Gutierrez, D., Ring, J., Schroeder, S., Magnes, C., Antonacci, L., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1975 · Cited by 1,680
Azad, M. B., Chen, Y., & Gibson, S. B. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2270 · Cited by 764
Balamuth, N., & Womer, R. B. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70286-4 · Cited by 727
Salazar‐Roa, M., Carracedo, A., Salanueva, Í. J., Hernández‐Tiedra, S., Lorente, M., Egia, A., Vázquez, P., Blázquez, C., Torres, S., Garcia, S., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37948 · Cited by 700
Mechanisms of drug resistance in colon cancer and its therapeutic strategies
Hu, T., Li, Z., Gao, C.-Y., & Cho, C. H. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i30.6876 · Cited by 381
Metabolic Reprogramming in Glioma
Strickland, M., & Stoll, E. A. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00043 · Cited by 357
Chemical modulators of autophagy as biological probes and potential therapeutics
Fleming, A., Noda, T., Yoshimori, T., & Rubinsztein, D. C. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.500 · Cited by 358
A Combined Preclinical Therapy of Cannabinoids and Temozolomide against Glioma
Torres, S., Lorente, M., Rodríguez-Fornés, F., Hernández‐Tiedra, S., Salazar‐Roa, M., García-Taboada, E., Barcia, J. A., Guzmán, M., & Velasco, G. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0688 · Cited by 309
Peetla, C., Vijayaraghavalu, S., & Labhasetwar, V. D. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.004 · Cited by 300
Ivermectin Induces Cytostatic Autophagy by Blocking the PAK1/Akt Axis in Breast Cancer
Dou, Q., Chen, H., Wang, K., Yuan, K., Lei, Y., Li, K., Lan, J., Chen, Y., Huang, Z., Xie, N., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2887 · Cited by 260
Messaoudi, K., Clavreul, A., & Lagarce, F. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.02.011 · Cited by 238
Geng, Y., Kohli, L., Klocke, B. J., & Roth, K. A. (2010) · Neuro-Oncology · doi:10.1093/neuonc/nop048 · Cited by 217
Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme
Bai, R.-Y., Staedtke, V., Aprhys, C. M., Gallia, G. L., & Riggins, G. J. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor077 · Cited by 201
Histone deacetylase 10 structure and molecular function as a polyamine deacetylase
Hai, Y., Shinsky, S. A., Porter, N. J., & Christianson, D. W. (2017) · Nature Communications · doi:10.1038/ncomms15368 · Cited by 200
Banik, K., Ranaware, A. M., Deshpande, V., Nalawade, S. P., Padmavathi, G., Bordoloi, D., Sailo, B. L., Shanmugam, M. K., Fan, L., Arfuso, F., et al. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.04.004 · Cited by 191
Autophagy in tumour suppression and promotion
Brech, A., Ahlquist, T. C., Lothe, R. A., & Stenmark, H. (2009) · Molecular Oncology · doi:10.1016/j.molonc.2009.05.007 · Cited by 194
Filippi‐Chiela, E. C., Villodre, E. S., Zamin, L. L., & Lenz, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020849 · Cited by 181
Overmeyer, J. H., Young, A. M., Bhanot, H., & Maltese, W. A. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-69 · Cited by 174
Syed, N., Langer, J., Janczar, K., Singh, P., Nigro, C. L., Lattanzio, L., Coley, H. M., Hatzimichael, E. C., Bomalaski, J. S., Szlosarek, P. W., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2012.197 · Cited by 167
Autophagy induced by valproic acid is associated with oxidative stress in glioma cell lines
Fu, J., Shao, C.-J., Chen, F.-R., Ng, H., & Chen, Z. (2009) · Neuro-Oncology · doi:10.1093/neuonc/nop005 · Cited by 167
Comincini, S., Allavena, G., Palumbo, S., Morini, M., Durando, F., Angeletti, F., Pirtoli, L., & Miracco, C. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.24597 · Cited by 167
Autophagy—A double‐edged sword in oncology
Apel, A., Zentgraf, H., Büchler, M. W., & Herr, I. (2009) · International Journal of Cancer · doi:10.1002/ijc.24500 · Cited by 162
Ingrassia, L., Lefranc, F., Dewelle, J., Pottier, L. R., Mathieu, V., Spiegl‐Kreinecker, S., Sauvage, S., Yazidi, M. E., Dehoux, M., Berger, W., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm8013585 · Cited by 151
Self-citationProgrammed Cell Death Pathways and Current Antitumor Targets
Tan, M., Ooi, J. P., Ismail, N. I., Moad, A. I. H., & Muhammad, T. S. T. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9895-1 · Cited by 156
Ciechomska, I. A., Gabrusiewicz, K. R., Szczepankiewicz, A. A., & Kaminska, B. (2012) · Oncogene · doi:10.1038/onc.2012.174 · Cited by 144
Cell death and autophagy: Cytokines, drugs, and nutritional factors
Bursch, W., Karwan, A., Mayer, M., Dornetshuber, J., Fröhwein, U., Schulte‐Hermann, R., Fazi, B., Sano, F. D., Piredda, L., Piacentini, M., et al. (2008) · Toxicology · doi:10.1016/j.tox.2008.07.048 · Cited by 142
Shikonin Kills Glioma Cells through Necroptosis Mediated by RIP-1
Huang, C., Luo, Y., Zhao, J., Yang, F., Zhao, H., Fan, W., & Ge, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066326 · Cited by 139
Cheng, Y., Zhang, Y., Zhang, L., Ren, X., Huber-Keener, K. J., Liu, X., Zhou, L., Liao, J., Keihack, H., Li, Y., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0606 · Cited by 135
Lectin of Concanavalin A as an anti-hepatoma therapeutic agent
Lei, H.-Y., & Chang, C. (2009) · Journal of Biomedical Science · doi:10.1186/1423-0127-16-10 · Cited by 128
Calvé, B. L., Rynkowski, M. A., Mercier, M. L., Bruyère, C., Lonez, C., Gras, T., Haibe‐Kains, B., Bontempi, G., Decaestecker, C., Ruysschaert, J., et al. (2010) · Neoplasia · doi:10.1593/neo.10526 · Cited by 126
Self-citationMathieu, V., Nève, N. D., Mercier, M. L., Dewelle, J., Gaussin, J., Dehoux, M., Robert Kiss, A., & Lefranc, F. (2008) · Neoplasia · doi:10.1593/neo.08928 · Cited by 124
Self-citationAn autophagy‐related long non‐coding RNA signature for glioma
Luan, F., Chen, W., Chen, M., Yan, J., Chen, H., Yu, H., Liu, T., & Mo, L. (2019) · FEBS Open Bio · doi:10.1002/2211-5463.12601 · Cited by 119
The sodium pump α1 sub‐unit: a disease progression–related target for metastatic melanoma treatment
Mathieu, V., Pirker, C., de Lassalle, E. M., Vernier, M., Mijatovic, T., DeNeve, N., Gaussin, J., Dehoux, M., Lefranc, F., Berger, W., et al. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00708.x · Cited by 118
Self-citationSchleicher, S. M., Moretti, L., Varki, V., & Lu, J. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.04.002 · Cited by 121
Christmann, M., Nagel, G., Horn, S., Krahn, U., Wiewrodt, D., Sommer, C., & Kaina, B. (2010) · International Journal of Cancer · doi:10.1002/ijc.25229 · Cited by 117
Filippi‐Chiela, E. C., Thomé, M. P. M., Silva, M. M. B. E., Pelegrini, A. L., Ledur, P. F., Garicochea, B., Zamin, L. L., & Lenz, G. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-147 · Cited by 120
Novel Insights into the Interplay between Apoptosis and Autophagy
Rikiishi, H. (2012) · International Journal of Cell Biology · doi:10.1155/2012/317645 · Cited by 117
The Sodium Pump α1 Subunit as a Potential Target to Combat Apoptosis-Resistant Glioblastomas
Lefranc, F., & Robert Kiss, A. (2008) · Neoplasia · doi:10.1593/neo.07928 · Cited by 113
Self-citationEfficacy of monoterpene perillyl alcohol upon survival rate of patients with recurrent glioblastoma
da Fonseca, C. O., Simão, M., Lins, I. R., Caetano, R. O., Futuro, D. O., & Quírico‐Santos, T. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0873-0 · Cited by 112
Wu, J.-C., Lai, C., Badmaev, V., Nagabhushanam, K., Ho, C., & Pan, M. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100454 · Cited by 113
A Novel Sphingosine Kinase Inhibitor Induces Autophagy in Tumor Cells
Beljanski, V., Knaak, C., & Smith, C. D. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.163337 · Cited by 111
Mercier, M. L., Ensign, S. P. F., Mathieu, V., Robert Kiss, A., & Lefranc, F. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00270.x · Cited by 115
Self-citationChen, Y., Azad, M. B., & Gibson, S. B. (2010) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y10-010 · Cited by 108
Characterization of Isoenzyme-Selective Inhibitors of Human Sphingosine Kinases
Gao, P., Peterson, Y. K., Smith, R. A., & Smith, C. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044543 · Cited by 110
Terés, S., Lladó, V., Higuera, M., Barceló‐Coblijn, G., Martín, M. L., Noguera-Salvà, M. A., Marcilla-Etxenike, A., García‐Verdugo, J. M., Soriano‐Navarro, M., Saus, C., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118349109 · Cited by 104
Goietsenoven, G. V., Mathieu, V., Lefranc, F., Kornienko, A., Evidente, A., & Robert Kiss, A. (2012) · Medicinal Research Reviews · doi:10.1002/med.21253 · Cited by 103
Self-citationEnhancement of autophagy is a potential modality for tumors refractory to radiotherapy
Kuwahara, Y., Oikawa, T., Ochiai, Y., Roudkenar, M. H., Fukumoto, M., Shimura, T., Ohtake, Y., Ohkubo, Y., Mori, S., Uchiyama, Y., et al. (2011) · Cell Death and Disease · doi:10.1038/cddis.2011.56 · Cited by 99
Ye, R., Dai, N., He, Q., Guo, P., Xiang, Y., Zhang, Q., Hong, Z., & Zhang, Q. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.06.065 · Cited by 98
Jiang, C., Shen, F., Du, J., Fang, X., Li, X., Su, J., Wang, X., Huang, X., & Liu, Z. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.10.146 · Cited by 97
Jakubowicz-Gil, J., Langner, E., Bądziul, D., Wertel, I., & Rzeski, W. (2013) · Tumor Biology · doi:10.1007/s13277-013-0785-0 · Cited by 96
Cloonan, S. M., & Williams, D. C. (2010) · International Journal of Cancer · doi:10.1002/ijc.25477 · Cited by 98
Therapeutic Agents Triggering Nonapoptotic Cancer Cell Death
Kornienko, A., Mathieu, V., Rastogi, S. K., Lefranc, F., & Robert Kiss, A. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400136m · Cited by 90
Self-citationHuang, G., Liu, Z., He, L., Luk, K.-H., Cheung, S.-T., Wong, K., & Chen, T. (2018) · Biomaterials Science · doi:10.1039/c8bm00670a · Cited by 91
DR5‐mediated DISC controls caspase‐8 cleavage and initiation of apoptosis in human glioblastomas
Bellail, A. C., Tse, M. C. L., Song, J. H., Phuphanich, S., Olson, J. J., Sun, S. Y., & Hao, C. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00777.x · Cited by 88
mTOR-Dependent Cell Proliferation in the Brain
Ryskalin, L., Lazzeri, G., Flaibani, M., Biagioni, F., Gambardella, S., Frati, A., & Fornai, F. (2017) · BioMed Research International · doi:10.1155/2017/7082696 · Cited by 86
Phospholipase D2 Mediates Survival Signaling through Direct Regulation of Akt in Glioblastoma Cells
Bruntz, R. C., Taylor, H. E., Lindsley, C. W., & Brown, H. A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.532978 · Cited by 84
Fenretinide induces autophagic cell death in caspase-defective breast cancer cells
Fazi, B., Bursch, W., Fimia, G. M., Nardacci, R., Piacentini, M., Sano, F. D., & Piredda, L. (2008) · Autophagy · doi:10.4161/auto.5669 · Cited by 81
Present and potential future adjuvant issues in high-grade astrocytic glioma treatment
Lefranc, F., Rynkowski, M. A., Dewitte, O., & Robert Kiss, A. (2009) · Advances and technical standards in neurosurgery · doi:10.1007/978-3-211-78741-0_1 · Cited by 78
Self-citationTemozolomide and Other Potential Agents for the Treatment of Glioblastoma Multiforme
Nagasawa, D. T., Chow, F. E., Yew, A. Y., Kim, W. B., Cremer, N., & Yang, I. (2012) · Neurosurgery Clinics of North America · doi:10.1016/j.nec.2012.01.007 · Cited by 76
Rapamycin inhibits the growth of glioblastoma
Arcella, A., Biagioni, F., Oliva, M. A., Bucci, D., Frati, A., Esposito, V., Cantore, G., Giangaspero, F., & Fornai, F. (2012) · Brain Research · doi:10.1016/j.brainres.2012.11.044 · Cited by 77
Coupienne, I., Bontems, S., Dewaele, M., Rubio, N., Habraken, Y., Fulda, S., Agostinis, P., & Piette, J. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.12.015 · Cited by 83
Arabzadeh, A., Mortezazadeh, T., Aryafar, T., Gharepapagh, E., Majdaeen, M., & Farhood, B. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02099-0 · Cited by 77
The Future of Glioblastoma Therapy: Synergism of Standard of Care and Immunotherapy
Patel, M. A., Kim, J., Ruzevick, J., Li, G., & Lim, M. K. (2014) · Cancers · doi:10.3390/cancers6041953 · Cited by 73
Mercier, M. L., Ensign, S. P. F., Mathieu, V., Roland, I. H., Spiegl‐Kreinecker, S., Haibe‐Kains, B., Bontempi, G., Decaestecker, C., Berger, W., Lefranc, F., et al. (2009) · Neoplasia · doi:10.1593/neo.81526 · Cited by 70
Self-citationTemozolomide, quercetin and cell death in the MOGGCCM astrocytoma cell line
Jakubowicz-Gil, J., Langner, E., Wertel, I., Piersiak, T., & Rzeski, W. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.07.015 · Cited by 70
Paulino, V. M., Yang, Z., Kloss, J. M., Ennis, M. J., Armstrong, B. A., Loftus, J. C., & Tran, N. L. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0334 · Cited by 70
Derenne, A., Hemelryck, V. V., Lamoral‐Theys, D., Robert Kiss, A., & Goormaghtigh, E. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.10.010 · Cited by 69
High Autophagy in the Naked Mole Rat may Play a Significant Role in Maintaining Good Health
Zhao, S., Lin, L., Kan, G., Xu, C., Tang, Q., Yu, C., Sun, W., Cai, L., Chen, X., & Cui, S. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000356672 · Cited by 70
Oncogenic B-RAF Signaling in Melanoma Impairs the Therapeutic Advantage of Autophagy Inhibition
Armstrong, J. L., Corazzari, M., Martin, S., Pagliarini, V., Falasca, L., Hill, D. S., Ellis, N., Al Sabah, S., Redfern, C. P. F., Fimia, G. M., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3003 · Cited by 65
Metformin treatment reduces temozolomide resistance of glioblastoma cells
Yang, S. H., Li, S., Lu, G., Xue, H., Kim, D., Zhu, J., & Liu, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.12859 · Cited by 66
Cryptotanshinone induces ROS-dependent autophagy in multidrug-resistant colon cancer cells
Xu, Z., Jiang, H., Zhu, Y., Wang, H., Jiang, J., Chen, L., Xu, W., Hu, T., & Cho, C. H. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.06.003 · Cited by 65
Glioblastoma stem cells resistant to temozolomide-induced autophagy.
Fu, J., Liu, Z.-G., Liu, X., Chen, F., Hong-liu, S., Pangjesse, C.-S., Ng, H., & Chen, Z. (2009) · PubMed · doi:10.3760/cma.j.issn.0366-6999.2009.11.004 · Cited by 64
Fiedler, T., Strauß, M., Hering, S., Redanz, U., William, D., Rosche, Y., Classen, C. F., Kreikemeyer, B., Linnebacher, M., & Maletzki, C. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1026478 · Cited by 63
Yan, Y., Bai, J., Xie, Y., Yu, J., & Ma, C. (2012) · Oncology Letters · doi:10.3892/ol.2012.982 · Cited by 61
Chapter 13 Autophagy Pathways in Glioblastoma
Jiang, H., White, E. J., Conrad, C. A., Gomez‐Manzano, C., & Fueyo-Margareto, J. (2009) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(08)04013-5 · Cited by 61
Oleuropein Induces AMPK-Dependent Autophagy in NAFLD Mice, Regardless of the Gender
Porcu, C., Sideri, S., Martini, M., Cocomazzi, A., Galli, A., Tarantino, G., & Balsano, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123948 · Cited by 58
Chang, C.-H., Bijian, K., Wernic, D., Su, J., da Silva, S. D., Yu, H. G., Qiu, D., Asslan, M., & Alaoui‐Jamali, M. A. (2019) · Autophagy · doi:10.1080/15548627.2019.1582951 · Cited by 59
Jakubowicz-Gil, J., Langner, E., Bądziul, D., Wertel, I., & Rzeski, W. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.10.003 · Cited by 57
Honokiol-induced apoptosis and autophagy in glioblastoma multiforme cells
Chang, K.-H., Yan, M., Yao, C., LIN, P.-C., & Lai, G. (2013) · Oncology Letters · doi:10.3892/ol.2013.1548 · Cited by 57
Ghosh, S., Bishayee, K., & Khuda‐Bukhsh, A. R. (2013) · Phytotherapy Research · doi:10.1002/ptr.5107 · Cited by 57
Mora-Rodríguez, R. A., Abschuetz, A., Kees, T., Đokić, I., Joschko, N., Kleber, S., Geibig, R., Mosconi, E., Zentgraf, H., Martín-Villalba, A., et al. (2008) · Glia · doi:10.1002/glia.20785 · Cited by 57
Cho, M., Park, G.-M., Kim, S., Amna, T., Lee, S., & Shin, W. (2014) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.1308.08090 · Cited by 56
Cheng, Y. H., & Xie, P. (2019) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22392 · Cited by 55
Clinical and Molecular Insights into Tuberous Sclerosis Complex Renal Disease
Siroky, B. J., Yin, H. J., & Bissler, J. J. (2010) · Pediatric Nephrology · doi:10.1007/s00467-010-1689-5 · Cited by 55
Galectin-1, a gene preferentially expressed at the tumor margin, promotes glioblastoma cell invasion
Toussaint, L. G., Nilson, A. E., Goble, J. M., Ballman, K. V., James, C. D., Lefranc, F., Robert Kiss, A., & Uhm, J. H. (2012) · Molecular Cancer · doi:10.1186/1476-4598-11-32 · Cited by 58
Self-citationMendoza-Maldonado, R., Faoro, V., Bajpai, S., Berti, M., Odreman, F., Vindigni, M., Ius, T., Ghasemian, A., Bonin, S., Škrap, M., et al. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-83 · Cited by 54
Hwang, M.-S., & Baek, W. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.07.050 · Cited by 55
Berstein, L. M., Yue, W., Wang, J., & Santen, R. J. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1072-z · Cited by 55
Giussani, P., Bassi, R., Anelli, V., Brioschi, L., Zen, F. D., Riccitelli, E., Caroli, M., Campanella, R., Gaini, S. M., Viani, P., et al. (2012) · Cancer Investigation · doi:10.3109/07357907.2011.629379 · Cited by 52
Oh, E., Hong, J., Kwon, O., & Yun, C. (2018) · Scientific Reports · doi:10.1038/s41598-018-19300-6 · Cited by 51
Glioblastoma therapy: going beyond Hercules Columns
Mangiola, A., Anile, C., Pompucci, A., Capone, G., Rigante, L., & BONIS, P. D. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.158 · Cited by 50
Autophagy: from basic science to clinical application
Limbergen, J. V., Stevens, C., Nimmo, E., Wilson, D., & Satsangi, J. (2009) · Mucosal Immunology · doi:10.1038/mi.2009.20 · Cited by 53
Clinically relevant radioresistant cell line: a simple model to understand cancer radioresistance
Kuwahara, Y., Roudkenar, M. H., Urushihara, Y., Saito, Y., Tomita, K., Roushandeh, A. M., Sato, T., Kurimasa, A., & Fukumoto, M. (2017) · Medical Molecular Morphology · doi:10.1007/s00795-017-0171-x · Cited by 50
Yang, L., Liu, Y., Wang, M., Qian, Y., Dai, X., Zhu, Y., Chen, J., Guo, S., & Hisamitsu, T. (2016) · Oncology Letters · doi:10.3892/ol.2016.5213 · Cited by 49
Cilengitide induces autophagy-mediated cell death in glioma cells
Lomonaco, S. L., Finniss, S., Xiang, C., Lee, H. K., Jiang, W., Lemke, N. W., Rempel, S. A., Mikkelsen, T., & Brodie, C. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor073 · Cited by 47
Padmakrishnan, C. J., Easwer, H. V., Vijayakurup, V., Menon, G. R., Nair, S., & Gopala, S. (2017) · Pathology & Oncology Research · doi:10.1007/s12253-017-0310-7 · Cited by 47
Autophagy inhibition enhances sensitivity of endometrial carcinoma cells to paclitaxel
Liu, S., & Li, X. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.2937 · Cited by 47
Chen, Z., Guo, Y., & Li, X. (2022) · Natural Product Reports · doi:10.1039/d2np00021k · Cited by 45
Mégalizzi, V., Decaestecker, C., Debeir, O., Spiegl‐Kreinecker, S., Berger, W., Lefranc, F., Kast, R. E., & Robert Kiss, A. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.07.011 · Cited by 45
Self-citationTemozolomide-induced modification of the CXC chemokine network in experimental gliomas
Kiss (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.964 · Cited by 45
Metadata
- Authors
- Lefranc, F., Facchini, V., & Kiss, R.
- Affiliations
- Université Libre de Bruxelles (BE)
- c Unibioscreen SA, Brussels, Belgium
- b Laboratory of Toxicology, Institute of Pharmacy, Université Libre de Bruxelles, Brussels, Belgium
- Corresponding author
- Lefranc, Florence
- Venue
- The Oncologist
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-12-01
- Volume
- 12
- Issue
- 12
- Pages
- 1395-1403
- ISSN
- 1083-7159 (ISSN-L)
- 1549-490X
- OpenAlex
- W2099551830
- Cited by
- 237
- References
- 93
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 7 · 2022: 7 · 2021: 7 · 2020: 5 · 2019: 7 · 2018: 11 · 2017: 14 · 2016: 10 · 2015: 13 · 2014: 13 · 2013: 21 · 2012: 19
- FWCI
- 2.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- The Oncologist (publishedVersion)
- PubMed (publishedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Keywords
- autophagic cell death, apoptosis resistance, glioblastoma, temozolomide, mTOR inhibitors, PI3K/Akt signaling, endoplasmic reticulum stress, combination chemotherapy, caspase-independent cell death
- MeSH terms
- Temozolomide, Antineoplastic Agents, Autophagy, Dacarbazine, Glioblastoma, Humans, Neoplasms, Drug Delivery Systems, Apoptosis, Drug Resistance, Neoplasm
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review